Re-induction with Ipilimumab, GP100 peptide vaccine, or a combination of both in a phase III study of previously-treated patient with advanced melanoma:: Update of clinical characteristics of patients.

C. Robert; F. S. Hodi; S. J. O'Day; C. Peschel; C. H. Ottensmeier; U. Trefzer; P. Lorigan; M. Messina; R. Ibrahim; D. Schadendorf

Re-induction with Ipilimumab, GP100 peptide vaccine, or a combination of both in a phase III study of previously-treated patient with advanced melanoma: Update of clinical characteristics of patients.

C. Robert, F. S. Hodi, S. J. O'Day, C. Peschel, C. H. Ottensmeier, U. Trefzer, P. Lorigan, M. Messina, R. Ibrahim, D. Schadendorf

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Pages (from-to)	403-404
Number of pages	2
Journal	Annals of Oncology
Volume	21
Issue number	Supplement 8
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Robert, C., Hodi, F. S., O'Day, S. J., Peschel, C., Ottensmeier, C. H., Trefzer, U., Lorigan, P., Messina, M., Ibrahim, R., & Schadendorf, D. (2010). Re-induction with Ipilimumab, GP100 peptide vaccine, or a combination of both in a phase III study of previously-treated patient with advanced melanoma: Update of clinical characteristics of patients. Annals of Oncology, 21(Supplement 8), 403-404.

@article{61094f9df45a43dfa010d1480a4c5742,

title = "Re-induction with Ipilimumab, GP100 peptide vaccine, or a combination of both in a phase III study of previously-treated patient with advanced melanoma:: Update of clinical characteristics of patients.",

author = "C. Robert and Hodi, {F. S.} and O'Day, {S. J.} and C. Peschel and Ottensmeier, {C. H.} and U. Trefzer and P. Lorigan and M. Messina and R. Ibrahim and D. Schadendorf",

year = "2010",

language = "Undefined",

volume = "21",

pages = "403--404",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Supplement 8",

}

Robert, C, Hodi, FS, O'Day, SJ, Peschel, C, Ottensmeier, CH, Trefzer, U, Lorigan, P, Messina, M, Ibrahim, R & Schadendorf, D 2010, 'Re-induction with Ipilimumab, GP100 peptide vaccine, or a combination of both in a phase III study of previously-treated patient with advanced melanoma: Update of clinical characteristics of patients.', Annals of Oncology, vol. 21, no. Supplement 8, pp. 403-404.

Re-induction with Ipilimumab, GP100 peptide vaccine, or a combination of both in a phase III study of previously-treated patient with advanced melanoma: Update of clinical characteristics of patients. / Robert, C.; Hodi, F. S.; O'Day, S. J. et al.
In: Annals of Oncology, Vol. 21, No. Supplement 8, 2010, p. 403-404.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Re-induction with Ipilimumab, GP100 peptide vaccine, or a combination of both in a phase III study of previously-treated patient with advanced melanoma:

T2 - Update of clinical characteristics of patients.

AU - Robert, C.

AU - Hodi, F. S.

AU - O'Day, S. J.

AU - Peschel, C.

AU - Ottensmeier, C. H.

AU - Trefzer, U.

AU - Lorigan, P.

AU - Messina, M.

AU - Ibrahim, R.

AU - Schadendorf, D.

PY - 2010

Y1 - 2010

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000284592300531&KeyUID=WOS:000284592300531

M3 - Article

SN - 0923-7534

VL - 21

SP - 403

EP - 404

JO - Annals of Oncology

JF - Annals of Oncology

IS - Supplement 8

ER -

Re-induction with Ipilimumab, GP100 peptide vaccine, or a combination of both in a phase III study of previously-treated patient with advanced melanoma: Update of clinical characteristics of patients.

UN SDGs

Other files and links

Cite this